In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person: (1) Has a terminal illness; 1015 31-52-5 (2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration; (3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and (4) Has given written informed consent for the use of the investigational drug, biological product, or device. History. — Code 1981, § 31-52-4, enacted by Ga. L. 2016, p. 345, § 1/HB 34. 31-52-5. Written informed consent.
Eligibility criteria
O.C.G.A. § 31-52-4 — under Title 31.
O.C.G.A. § 31-52-4